Heart Rhythm Disorders. How do you quantify risk?

Similar documents
Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Tachycardia Devices Indications and Basic Trouble Shooting

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Tachycardias II. Štěpán Havránek

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

ECG Workshop. Carolyn Shepherd And Anya Horne UWE Principles of Cardiac Care

Arrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine

SUDDEN CARDIAC DEATH(SCD): Definition

Remote Monitoring & the Smart Home of the 21 Century

Management of Syncope in Heart Failure. University of Iowa

Antony French Consultant Cardiologist & Electrophysiologist

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Management of Arrhythmias The General Practitioners role

ECTOPIC BEATS: HOW MANY COUNT?

SUDDEN CARDIAC DEATH(SCD): Definition

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Supplementary Online Content

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Tehran Arrhythmia Center

Ventricular Tachycardia in Structurally Normal Hearts (Idiopathic VT) Patient Information

Syncope Guidelines What s new? October 19 th 2017 Mohamed Aljaabari MBBCh, FACC, FHRS Consultant Electrophysiologist - Mafraq Hospital

Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology

Prophylactic ablation

APPROACH TO TACHYARRYTHMIAS

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

Lee Chee Wan. Senior Consultant Pacing and Cardiac Electrophysiology. GP Symposium 2 nd April 2016

Arrhythmias Focused Review. Who Needs An ICD?

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

ICD in a young patient with syncope

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006

Junctional Premature Contraction (JPC)

Syncope in ED-Risk Stratification Ger McMahon

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Paroxysmal Supraventricular Tachycardia PSVT.

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Sudden cardiac death: Primary and secondary prevention

Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof of Cardiology, University Hospital of Crete

2) Heart Arrhythmias 2 - Dr. Abdullah Sharif

Arrhythmias on the AMU

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013

ESC Stockholm Arrhythmias & pacing

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ

Silvia G Priori MD PhD

Atrial fibrillation (AF) is a disorder seen

Syncope: Evaluation of the Weak and Dizzy

Syncope: Evaluation of the Weak and Dizzy

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

TACHYARRHYTHMIAs. Pawel Balsam, MD, PhD

Summary, conclusions and future perspectives

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias

UNDERSTANDING YOUR ECG: A REVIEW

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Secondary prevention of sudden cardiac death

Ventricular arrhythmias in acute coronary syndromes. Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Unknown ECGs for the Clinician

Return to Basics. ECG Rate and Rhythm. Management of the Hospitalized Patient September 25, 2009

Update on Palpitations and AF February 28 th 2018

What Every Physician Should Know:

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Return to Basics. Normal Intervals & Axes. ECG Rate and Rhythm

CME Article Brugada pattern masking anterior myocardial infarction

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Huseng Vefali MD St. Luke s University Health Network Department of Cardiology

that number is extremely high. It s 16 episodes, or in other words, it s 14, one-four, ICD shocks per patient per day.

ECG S: A CASE-BASED APPROACH December 6,

Subclinical AF: Implications of device based episodes

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

Ventricular tachycardia Ventricular fibrillation and ICD

Ambulatory ECG Monitoring. Gill Bouncir Blackpool Victoria Hospital

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

AHA/ACC Scientific Statement

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Automatic External Defibrillators

FANS Paediatric Pathway for Inherited Arrhythmias*

Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis

Distinguishing Cardiac from Non- Cardiac Syncope

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU

Different indications for pacemaker implantation are the following:

Transcription:

Heart Rhythm Disorders How do you quantify risk?

Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life. Palpitations = 1/3 all referrals to cardiology 1% all A&E attendances due to T-LOC

Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life. Palpitations = 1/3 all referrals to cardiology 1% all A&E attendances due to T-LOC Benign Fatal (Cardiac Arrest)

Recurrent Transient Loss of Consciousness T-LOC Cerebral Hypoperfusion Transient LOC Loss of postural tone Syncope

Syncope Transient loss of consciousness due to cerebral hypoperfusion Postural BP 20% > 90% patients with cardiac syncope have a benign condition with a normal life expectancy Reflex 70% Cardiac 10% Tachycardia Bradycardia Mechanical Obstruction < 10% patients with cardiac syncope have a potentially life-threatening condition

Prognosis Framingham Heart Study 1971-1998 - No Syncope - Reflex Cardiac Adapted from Soteriades E et al. NEJM 2002; 347: 878-85

Prognosis Framingham Heart Study 1971-1998 - No Syncope - Reflex Cardiac Adapted from Soteriades E et al. NEJM 2002; 347: 878-85

Palpitations An abnormal awareness of the heart beat

Palpitations An abnormal awareness of the heart beat Paroxysmal Sustained Tachycardias AV node dependent tachycardias Atrial tachyarrhythmias Ventricular tachyarrhythmias Ectopics

Palpitations An abnormal awareness of the heart beat Paroxysmal Sustained Tachycardias Ectopics AV node dependent tachycardias (Curable!) Atrial tachyarrhythmias Ventricular tachyarrhythmias

Palpitations An abnormal awareness of the heart beats Paroxysmal Sustained Tachycardias AV node dependent tachycardias Atrial tachyarrhythmias Ventricular tachyarrhythmias Ectopics

CHADS-VASc Score and Stroke Risk Lip G et al. The Euro Heart Survey on AF. Chest 2010; 137: 263-72.

Danish National Registry CHADS-VASc n(%) Thromboembolism / Score 121,280 (100) 100 person years 0 10125 (8.4) 0.8 1 14526 (12.0) 2.0 2 22115 (18.2) 3.7 3 27834 (23.0) 5.9 4 22676 (18.7) 9.3 5 14213 (11.7) 15.6 6 6927 (5.7) 19.7 7 2327 (1.9) 21.5 8 467 (0.4) 22.4 9 70 (0.1) 23.6 Olsen J. BMJ On-line First 2011

Assessing Risk in Atrial Tachyarrhythmias (AT, AFL, Afib) CHADSVASc Score = Annual stroke risk Oral anticoagulation reduces risk by 2/3 Aspirin confers little benefit (20% reduction)

Danish National Registry CHADS-VASc n(%) Thromboembolism / Score 121,280 (100) 100 person years 0 10125 (8.4) 0.8 1 14526 (12.0) 2.0 2 22115 (18.2) 3.7 3 27834 (23.0) 5.9 4 22676 (18.7) 9.3 5 14213 (11.7) 15.6 6 6927 (5.7) 19.7 7 2327 (1.9) 21.5 8 467 (0.4) 22.4 9 70 (0.1) 23.6 Warfarin 2% Olsen J. BMJ On-line First 2011

Palpitations An abnormal awareness of the heart beat Paroxysmal Sustained Tachycardias AV node dependent tachycardias Atrial tachyarrhythmias Ventricular tachyarrhythmias - Scar related VT - Normal Heart VT Ectopics

Ventricular Tachycardia (Scar Related VT)

Conduction Velocity dependent on Fibre orientation

Reentry Scar related VT Peri-infarct Zone

Peri-Infarct Zone

VT initiation *

VT initiation

Reentry Scar related VT

Atherosclerosis Pathophysiology of Cardiac Arrest Myocardial Infarction SCAR Pulseless VT/VF Cardiac Arrest

Atherosclerosis Myocardial Infarction Pathophysiology of Cardiac Arrest 100,000 deaths per year 12% all natural deaths SCAR Q waves on ECG Scar inversely proportional to Ejection fraction EF < 35% - Consider primary prevention ICD Pulseless VT/VF Cardiac Arrest

Atherosclerosis Pathophysiology of Cardiac Arrest Myocardial Infarction SCAR Syncopal VT Pulseless VT/VF Cardiac Arrest

Atherosclerosis Pathophysiology of Cardiac Arrest Myocardial Infarction SCAR A patient with unexplained syncope and significant structural heart disease should be considered to have survived a life threatening event until proven otherwise Syncopal VT Pulseless VT/VF Cardiac Arrest 10%/yr

Palpitations An abnormal awareness of the heart beats Paroxysmal Sustained Tachycardias AV node dependent tachycardias Atrial tachyarrhythmias Ventricular tachyarrhythmias Ectopics

Ventricular Ectopics Benign or Marker of Disease?

Prior MI Myocarditis DCM Alcohol Pathophysiology of Cardiac Arrest SCAR Ventricular ectopics Non-sustained VT Pulseless VT/VF Cardiac Arrest Scar burden? Ischaemic burden?

Ectopics Risk stratification Morphology Low Unifocal RVOT focus Higher Multifocal Timing Rest On exercise Frequency Single < 10% Couplets Triplets (NSVT) > 10% Exercise Suppresses Increased frequency Exercise capacity Normal Reduced Echocardiogram Normal Abnormal ECG Normal Abnormal FHx ICC No Yes

Causes of SCD by age # Deaths per million/yr 2500 2000 1500 1000 500 0 0 10 20 30 40 50 60 70 80 90 CAD Cardiomyopathy Channelopathy Age (yrs) Dr Joe Galvin, Mater Hospital

Causes of SCD under 30 years 300 # Deaths per million/yr 250 200 150 100 50 0 0 10 20 30 CAD Cardiomyopathy Channelopathy Other Age (yrs) The majority of sudden unexplained deaths < 30 years are due to inherited cardiac conditions ~ 400/year in England

Heart Rhythm Disorders Unexplained T-LOC, undocumented tachycardias or ectopic beats Who is low risk? Structurally normal heart Normal 12 lead ECG No FHx sudden death < 35 years

Heart Rhythm Disorders Unexplained T-LOC, undocumented tachycardias or ectopic beats Who is high risk? Significant structurally normal heart Relevant 12 lead ECG abnormality FHx sudden death < 35 years

Low Risk Zero Risk

Inherited Cardiac Conditions How do you Quantify Risk? Case 1 Case 2 32 year old female 32 year old female Father died suddenly aged 44 Father still alive 56yrs Brother died suddenly aged 12 No FHx sudden death Gene + Gene + QTc = 465ms QTc = 540ms Phenotype expression determines individual risk

Prevent Sudden Death

External Defibrillator -999 First responder AED

Public Access Defibrillator

Implantable Cardioverter Defibrillator 6v battery Delivers 700v shock Defibrillates within 15s onset resulting in a success rate of 99.9% PG battery typically lasts 8 years

ICD implantation Day case procedure Local anaesthesia Conscious sedation

Rating a Patient with CAD and Prior MI Case 1 54 year old man 1 vessel disease Occluded Mid LAD Apical infarct EF = 45%

Rating a Patient with CAD and Prior MI Case 1 54 year old man 1 vessel disease Occluded Mid LAD Apical infarct EF = 45% Life rating + 150

Rating a Patient with CAD and Prior MI Case 1 54 year old man 1 vessel disease Occluded Mid LAD Apical infarct EF = 45% Life rating + 150 Case 2 54 year old cardiac arrest survivor 1 vessel disease Occluded mid LAD Apical infarct EF = 45% ICD in situ > 12 months Decline!

Rating a Patient with CAD and Prior MI Case 1 54 year old man 1 vessel disease Occluded Mid LAD Apical infarct EF = 45% Life rating + 150 At risk of future cardiac arrest Case 2 54 year old cardiac arrest survivor 1 vessel disease Occluded mid LAD Apical infarct EF = 45% ICD in situ > 12 months Decline! 99.9% protection from arrhythmic death

Conclusions Heart rhythm disorders very common & vast majority are benign (> 90% syncope) Heart rhythm disorders cause sudden death which is usually both predictable and preventable Atrial tachyarrhythmias should be rated on the basis of CHADSVASc score + anticoagulation status Cardiac arrest risk Scar Burden

Conclusions Diagnosing heart rhythm problems can be challenging In contrast risk stratification is easy! Phenotype not genotype determines individual risk Tachycardias are curable. Incurable life-threatening tachycardias can be treated with 99.9% effectiveness Low risk Zero risk and we frequently assess using suboptimal & incomplete data

Case Presentation 54 year old bus driver T-LOC x 1 RTA - Little warning, motionless x 2 min No other cardiac symptoms No FHx ICC DHx Nil SHX Smokes 20/day O/E NAD ECG Subtle Brugada changes & subtle pre-excitation

Case Presentation CT brain scan NAD Neurology Likely to be cardiac not neurological Echocardiogram Normal Diagnostic angiogram Normal Adenosine test Ve (No accessory pathway) Ajmaline test No Brugada ECG Prolonged inpatient monitoring NAD CCTV from the bus!

Incidence of Ventricular Premature Beats 60% 50% > 0 PVCs > 50 PVCs > 100 PVCs 40% 30% 20% 10% 0% 10-29 30-39 40-49 50-59 60-69 Age Data from Kostis JB. Circulation. 1981;63(6):1353.

Sajadieh et al Am J Cardiol 2006;97:1351-1357